Journal of Chemotherapy

3.0k papers and 31.4k indexed citations i.

About

The 3.0k papers published in Journal of Chemotherapy in the last decades have received a total of 31.4k indexed citations. Papers published in Journal of Chemotherapy usually cover Epidemiology (951 papers), Molecular Medicine (685 papers) and Pharmacology (661 papers) specifically the topics of Antibiotic Resistance in Bacteria (684 papers), Antibiotics Pharmacokinetics and Efficacy (614 papers) and Pneumonia and Respiratory Infections (334 papers). The most active scholars publishing in Journal of Chemotherapy are Vassilios Fanos, Ziad A. Memish, Mark Wainwright, Ronald N. Jones, Kent Crossley, Fernando Baquero, L Cataldi, P Periti, Hélio S. Sader and Rudolf Then.

In The Last Decade

Fields of papers published in Journal of Chemotherapy

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Journal of Chemotherapy. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Journal of Chemotherapy

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Journal of Chemotherapy. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Journal of Chemotherapy with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025